Today we heard of the row between drug company Roche and the - TopicsExpress



          

Today we heard of the row between drug company Roche and the British governments drug adviser, apparently negotiating over the last six months of the lives of women suffering from breast cancer. At issue was the £90,000 per patient that Roche is charging for the drug Kadcyla, which is not a cure but can extend life. Protected by what are known as intellectual property rights, the company has a legally sanctioned monopoly and is free to set its price...
Posted on: Wed, 23 Apr 2014 16:00:01 +0000

Trending Topics



Recently Viewed Topics




© 2015